Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Ahn

Showing results (261-270 of 274) with videos related to

Pageof 28
Sort By:
Blood Cancer Journal|July 8, 2024
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remissionMazyar Shadman, Kwang W Ahn, Manmeet Kaur, et al.
Blood|December 17, 2015
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donorsAbraham S Kanate, Alberto Mussetti, Mohamed A Kharfan-Dabaja, et al.
Blood|July 7, 2025
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysisMiguel-Angel Perales, Farrukh T Awan, Ariane Boumendil, et al.
Leukemia|May 15, 2024
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysisTrent P Wang, Kwang W Ahn, Mazyar Shadman, et al.
British Journal of Haematology|March 19, 2016
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantationTimothy S Fenske, Kwang W Ahn, Tara M Graff, et al.
Journal of Hematology & Oncology|January 12, 2019
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysisNarendranath Epperla, Kwang W Ahn, Carlos Litovich, et al.
British Journal of Haematology|August 4, 2017
Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysisAbraham S Kanate, Alyssa DiGilio, Kwang W Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 28, 2019
Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin LymphomaSairah Ahmed, Jennifer A Kanakry, Kwang W Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 16, 2017
Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research AnalysisCarla Casulo, Jonathan W Friedberg, Kwang W Ahn, et al.
Cancer|February 13, 2020
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantationDeepa Jagadeesh, Navneet S Majhail, Yizeng He, et al.
Pageof 28

Showing results (261-270 of 274) with videos related to

Sort By:
Pageof 28
Blood Cancer Journal|July 8, 2024
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remissionMazyar Shadman, Kwang W Ahn, Manmeet Kaur, et al.
Blood|December 17, 2015
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donorsAbraham S Kanate, Alberto Mussetti, Mohamed A Kharfan-Dabaja, et al.
Blood|July 7, 2025
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysisMiguel-Angel Perales, Farrukh T Awan, Ariane Boumendil, et al.
Leukemia|May 15, 2024
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysisTrent P Wang, Kwang W Ahn, Mazyar Shadman, et al.
British Journal of Haematology|March 19, 2016
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantationTimothy S Fenske, Kwang W Ahn, Tara M Graff, et al.
Journal of Hematology & Oncology|January 12, 2019
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysisNarendranath Epperla, Kwang W Ahn, Carlos Litovich, et al.
British Journal of Haematology|August 4, 2017
Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysisAbraham S Kanate, Alyssa DiGilio, Kwang W Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 28, 2019
Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin LymphomaSairah Ahmed, Jennifer A Kanakry, Kwang W Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 16, 2017
Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research AnalysisCarla Casulo, Jonathan W Friedberg, Kwang W Ahn, et al.
Cancer|February 13, 2020
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantationDeepa Jagadeesh, Navneet S Majhail, Yizeng He, et al.
Pageof 28